Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1.

Autor: Nagaraju GP; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA., Malla RR; Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, Institute of Science, GITAM (Deemed to be University), Visakhapatnam, AP, 530045, India., Basha R; Graduate School of Biomedical Sciences, The University of North Texas Health Science Center, Fort Worth, Texas, Department of Pediatrics and Women's Health, Texas College of Osteopathic Medicine, The University of North Texas Health Science Center, Fort Worth, TX, 76107, United States., Motofei IG; Department of Oncology/ Surgery, St. Pantelimon Hospital, Carol Davila University, Dionisie Lupu Street, No. 37, Bucharest, 020022, Romania. Electronic address: igmotofei@scholar.ro.

Publikováno v: Seminars in cancer biology [Semin Cancer Biol] 2022 Nov; Vol. 86 (Pt 3), pp. 616-621. Date of Electronic Publication: 2021 Nov 11.

Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity.

Autor: Motofei IG; Department of Surgery/ Oncology, Carol Davila University, Bucharest, Romania.; Department of Surgery/ Oncology, St. Pantelimon Hospital, Bucharest, Romania.

Publikováno v: Expert opinion on drug safety [Expert Opin Drug Saf] 2022 May; Vol. 21 (5), pp. 599-612. Date of Electronic Publication: 2021 Dec 27.